FAMDF (Futura Medical) 3-Year Revenue Growth Rate: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Futura Medical 3-Year Revenue Growth Rate?

Futura Medical FAMDF 3-Year Revenue Growth Rate is 0.00% as of Dec. 2025. The stock has 5 warning signs investors should review. Among 768 Biotechnology companies, Futura Medical ranks worse than 130208.2% on this metric.

Futura Medical's Revenue per Share for the six months ended in Dec. 2025 was $0.00.

During the past 12 months, Futura Medical's average Revenue per Share Growth Rate was -88.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Futura Medical was 35.70% per year. The lowest was -26.30% per year. And the median was -6.30% per year.

Futura Medical  (OTCPK:FAMDF) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Futura Medical 3-Year Revenue Growth Rate Related Terms

FAMDF vs VRTX, REGN, MRNA: 3-Year Revenue Growth Rate Comparison

For the Biotechnology subindustry, Futura Medical's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Futura Medical 3-Year Revenue Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Futura Medical's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Futura Medical's 3-Year Revenue Growth Rate falls into.


Futura Medical 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

What does a 3-Year Revenue Growth Rate of 0.00% mean?
Futura Medical (FAMDF) has a 3-Year Revenue Growth Rate of 0.00% as of Dec. 2025. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Futura Medical and its competitors. According to the industry distribution chart, Futura Medical ranks #999999 out of 768 companies in the Biotechnology industry.
Is Futura Medical's 3-Year Revenue Growth Rate too high?
Futura Medical's current 3-Year Revenue Growth Rate is 0.00%. Based on the distribution chart, Futura Medical ranks #999999 out of 768 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Futura Medical's 3-Year Revenue Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Futura Medical ranks #999999 out of 768 companies for 3-Year Revenue Growth Rate. This places Futura Medical in the lower half of its industry. The industry median 3-Year Revenue Growth Rate is 3.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Revenue Growth Rate for a Biotechnology company?
The median 3-Year Revenue Growth Rate among Biotechnology companies is 3.10, based on 768 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Revenue Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Revenue Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Revenue Growth Rate mean?
A high 3-Year Revenue Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Futura Medical and its competitors. For the Biotechnology industry, the median 3-Year Revenue Growth Rate is 3.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Futura Medical's current 3-Year Revenue Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Futura Medical stock overvalued right now?
Based on GuruFocus' analysis, Futura Medical (FAMDF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.08, compared to a current price of $0.00 — trading 96.9% below its estimated fair value. The current 3-Year Revenue Growth Rate is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Revenue Growth Rate calculated?
3-Year Revenue Growth Rate is calculated from a company's financial statements. For Futura Medical (FAMDF), the current 3-Year Revenue Growth Rate is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Futura Medical Business Description

Other Exchanges FUMl:UKFUM:UKGYX:Germany
Address 40 Occam Road, Surrey Technology Centre, Guildford, Surrey, GBR, GU2 7YG
Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives the majority of its revenue from the United Kingdom and the European Union.